<DOC>
	<DOCNO>NCT02042105</DOCNO>
	<brief_summary>This post-marketing , observational , non-interventional , multi-central study patient non-small cell lung cancer ( NSCLC ) , data collect prospectively medical record inclusion . The primary objective obtain epidemiologic data anaplastic lymphoma kinase ( ALK ) -positive unselected Chinese patient NSCLC .</brief_summary>
	<brief_title>A Prospective Epidemiologic Study ALK-Positive NSCLC China</brief_title>
	<detailed_description>Archived paraffin-embedded fresh frozen NSCLC tumor tissue obtain via Department Pathology . ALK positive status detect Ventana immunohistochemistry ( IHC ) ( Ventana Medical Systems , Inc. Roche Diagnostics International , Inc ) . When ALK positive patient detect , crizotinib administrate various solution base physician 's desecration patient ' willingness . The secondary objective include : 1.To obtain epidemiologic data ALK positive unselected Chinese patient NSCLC.2.To describe demographic , socioeconomic [ age , gender , race/ethnicity , geographic location ( include rural/urban area ) , pathologic parameter , education , family income , National Reimbursement Drug List ( NRDL ) Provincial Reimbursement List ( PRDL ) ] , clinical characteristic NSCLC patient ALK positive . The exploratory objective describe prognosis pattern associate crizotinib treated patient efficacy data available non-interventionally .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Adult patient ( â‰¥18 year ) , sex . Histologically cytologically proven diagnosis primary NSCLC , include squamous cell carcinoma adenocarcinoma . Written informed consent . Those lung cancer without pathological diagnosis include case type cancer , include small cell lung cancer ( SCLC ) metastatic disease organ .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>non-small-cell lung cancer</keyword>
	<keyword>anaplastic lymphoma kinase</keyword>
	<keyword>immunohistochemistry</keyword>
</DOC>